Dementia: caregiver support is feasible, but no benefit demonstrated for caregiver burden

A program can be well received without improving the main health outcomes measured. In a randomized pilot trial involving caregivers of people living at home with dementia, interdisciplinary support proved feasible. But no significant between-group difference was observed in caregiver burden or depressive symptoms. These findings come solely from the PubMed abstract consulted.

Illustration of a caregiver and a person with dementia talking with a healthcare professional.
MindsetEditorial illustration, not study data.

Support for both the person and their caregiver

The study evaluated a program combining rehabilitation for the person with dementia and information and support for their primary informal caregiver. Caregivers were randomly assigned, together with the person they supported, to either the program, with 36 caregivers, or usual care, with 31.

The program included an initial 20-week period and two four-week follow-up periods. Caregivers could receive assessments, group sessions and individual support. Their burden, depressive symptoms and health-related quality of life were assessed at baseline and then at 5, 12, 24 and 36 months by assessors who were unaware of their group assignment.

Participation was feasible, with encouraging but incomplete feedback

All 36 caregivers in the intervention group were assessed and received individual interventions from the team. Of these, 23 attended group sessions and 21 completed the questionnaire offered after the final session.

Among these respondents, 20 said they had a better understanding of how to support the person with dementia, and 19 reported better strategies for coping with difficulties. These responses describe the usefulness perceived by those who completed the questionnaire. On their own, they do not demonstrate reduced burden or improved mental health.

No demonstrated improvement in the main outcomes

The researchers observed no statistically significant between-group difference in depressive symptoms or caregiver burden. Some quality-of-life subscales even favored the usual-care group at 24 and 36 months. The abstract does not specify the magnitude of these differences, which limits their practical interpretation.

This pilot trial focused primarily on feasibility. Its limited sample size does not allow all possible benefits to be ruled out. Conversely, positive questionnaire feedback does not justify presenting the program as effective.

What this study tells us

The strongest finding concerns the feasibility of offering this support and engaging caregivers in it. The authors consider evaluation in an adequately powered randomized trial worthwhile and suggest studying longer-term, ongoing support tailored to each caregiver.

There were also missing follow-up data, mainly due to deaths according to the abstract. At 36 months, participation in burden assessments was 69% in the intervention group and 61% in the control group. This limitation matters when interpreting the long-term results.

Limitations to keep in mind

Only the PubMed abstract was consulted, not the full text. The sample size is limited, follow-up data are missing, and the magnitude of the quality-of-life differences is not provided in the abstract. Funding and conflicts of interest were not checked.

What we can take away

This program appears feasible, but this pilot trial does not demonstrate that it reduces caregiver burden or depressive symptoms. Its clinical value remains to be confirmed.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.